UK approves Novo weight-loss pill to edge open European market - Reuters
UK approves Novo weight-loss pill to edge open European market Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Notable Quotes
"This is a landmark approval, making the UK the first country in Europe to approve Wegovy pill."
— Emil Kongshøj Larsen , Executive
"Weight-loss medication can potentially benefit many patients, and being able to take it in tablet form would certainly be easier than having to inject it."
— Prof Victoria Tzortziou Brown , Academic
"Expanding the range of effective treatments is important in helping people sustainably reduce caloric intakes within an increasingly obesogenic environment."
— Naveed Sattar , Academic
"The announcement was a major step forward in treating obesity, increasing access and enabling millions more people to get treatment."
— Jason Murphy , Executive
Key People
Emil Kongshøj Larsen is the executive vice-president for international operations at Novo Nordisk.
Jason Murphy is the head of pharmacy at Chemist4U.
Naveed Sattar is a professor of cardiometabolic medicine at the University of Glasgow.
Prof Victoria Tzortziou Brown is the president of the Royal College of GPs.
Locations
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxPVzEwbDlKNFYwUWN3bXdKTnZGeUczWEFmZ29wRW1JLU5jQmJPcGdVZWt2MTV3YnRaSDdDc05KZHkzdXJJRWlNY1dhVHlBXzVfVHBLRWgzZHAyUW1vNC1iSkxWTDYxT2JrOVNqNFY4bXZfODhDZWNtWmE2aV92LXdOZl9aWUlQelFLMlliLVo0RWZiNWdLRzYwbndwWTkxcG5HNDVRaE1qN3d3VjAxOG5XaVh3?oc=5" target="_blank">UK approves Novo weight-loss pill to edge open European market</a> <font color="#6f6f6f">Reuters</font>
Novo Nordisk's weight-loss pill has been approved in the UK, intensifying competition in the obesity treatment market as the company seeks to regain its lead against U.S. rival Eli Lilly.
The UK's Medicines and Healthcare products Regulatory Agency has approved the Wegovy weight-loss pill, making it available for private prescription to eligible patients in the UK.
The UK's Medicines and Healthcare products Regulatory Agency has approved the Wegovy weight loss pill, marking a significant milestone in obesity care in the UK.
Similar Stories
Related coverage based on topic and tags
Novo CEO says obesity market won't be winner-take-all battle with Lilly - reuters.com
Novo CEO says obesity market won't be winner-take-all battle with Lilly reuters.com
August 13, 2026 at 10:02 AMNew weight-loss pill approved for use in UK
Foundayo is made by Eli Lilly, the drug firm behind the Mounjaro jab.
August 10, 2026 at 03:25 PMNovo begins study to find lowest effective dose for Wegovy pill - Reuters
Novo begins study to find lowest effective dose for Wegovy pill Reuters
August 19, 2026 at 03:26 PMNovartis defeats UK court bid to invalidate blockbuster drug Entresto patent - Reuters
Novartis defeats UK court bid to invalidate blockbuster drug Entresto patent Reuters
August 13, 2026 at 09:31 PMLilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide - reuters.com
Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide reuters.com
August 12, 2026 at 10:27 AMBritish data group Quantexa exploring UK or US IPO - Reuters
British data group Quantexa exploring UK or US IPO Reuters
August 18, 2026 at 05:12 PM